Table 6.
Survival according to staining patterns of p21, p16, and p53 in patients with non-small cell lung cancer
| Median survival (months) | 95% CI | p Value | |
| Group | |||
| A | 41.00 | 27.09 to 49.91 | <0.0001 |
| B | 19.00 | 7.32 to 30.68 | |
| C | 10.00 | 8.70 to 11.30 |
Group A, no or only one adverse prognostic factor; group B, two adverse prognostic factors; group C, three adverse prognostic factors.
CI, confidence interval.